Descrição

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. A study by StrategyHelix indicates that the global acne medication market is expected to increase by US$ 2,037.0 milhões de 2022 para 2028, obtendo um CAGR de 5.2% durante o período de previsão.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for acne medication. The global acne medication market is segmented on the basis of therapeutic class, route of administration, type, and region. Based on therapeutic class, the global acne medication market is categorized into retinoids, antibiotics, hormonal agents, outros. The retinoids segment captured the largest share of the market in 2021. On the basis of route of administration, the global acne medication market has been segmented into topical, oral. The topical segment held the largest share of the global acne medication market in 2021 and is anticipated to hold its share during the forecast period. Por tipo, the global acne medication market has been segmented into prescription medicine, over-the-counter (OTC) medicine. Em 2021, the over-the-counter (OTC) medicine segment made up the largest share of revenue generated by the acne medication market. In terms of geography, the global acne medication market has been segmented into North America, Ásia-Pacífico, Europa, Rest of the World (ROW).

The global acne medication market is highly competitive. A partir de 2021, the major players in the global acne medication market were Allergan plc, Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestlé S.A.), GlaxoSmithKline Plc (GSK), Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the acne medication market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Therapeutic class: retinoids, antibiotics, hormonal agents, outros
Route of administration: topical, oral
Tipo: prescription medicine, over-the-counter (OTC) medicine
Região: América do Norte, Ásia-Pacífico, Europa, Rest of the World (ROW)
Anos considerados: este relatório cobre o período 2018 para 2028

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global acne medication market
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Acne medication market overview
Papel 3. Market breakdown by therapeutic class
– Retinoids
– Antibiotics
– Hormonal agents
– Outros
Papel 4. Market breakdown by route of administration
– Topical
– Oral
Papel 5. Market breakdown by type
– Prescription medicine
– Over-the-counter (OTC) medicine
Papel 6. Market breakdown by region
– América do Norte
– Ásia-Pacífico
– Europa
– Rest of the World (ROW)
Papel 7. Principais empresas
– Allergan plc
– Bausch Health Companies Inc.
– F. Hoffmann-la Roche Ltd.
– Galderma S.A. (Nestlé S.A.)
– GlaxoSmithKline Plc (GSK)
– Mylan N.V.
– Perrigo Company plc
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.
Sobre StrategyHelix
Isenção de responsabilidade